🚀 Gate Fun Chinese Meme Fever Keeps Rising!
Create, launch, and trade your own Meme tokens to share a 3,000 GT!
Post your Meme on Gate Square for a chance to win $600 in sharing rewards!
A total prize pool of $3,600 awaits all creative Meme masters 💥
🚀 Launch now: https://web3.gate.com/gatefun?tab=explore
🏆 Square Sharing Prizes:
1️⃣ Top Creator by Market Cap (1): $200 Futures Voucher + Gate X RedBull Backpack + Honor Poster
2️⃣ Most Popular Creator (1): $200 Futures Voucher + Gate X RedBull Backpack + Honor Poster
3️⃣ Lucky Participants (10): $20 Futures Voucher (for high-quality posts)
O
Anglikan: The only innovative drug project currently under research is ALK-N001.
Golden Ten Data on June 9, Anglikang issued a change announcement, the company's shares for 2 consecutive trading days closing price deviation of more than 20%, belongs to the abnormal fluctuation of stock trading. The company's current innovative drug project under development is only ALK-N001, which obtained the drug clinical trial approval notice in April 2025 and is still in the phase I clinical trial stage as of the disclosure date of this announcement. The R&D of innovative drugs has the characteristics of long cycle, large investment and high uncertainty, so investors should pay attention to investment risks.